John W. Kozarich, Director at LIGAND PHARMACEUTICALS INC (LGND), sold 467 shares at $195.80 ($91K) on 2025-12-01, disclosed to the SEC on 2025-12-03.
Scheduled sale ($91k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $193.86 | 92 | $18K | 19.5% |
| 2 | $194.76 | 179 | $35K | 38.1% |
| 3 | $195.80 | 47 | $9K | 10.1% |
| 4 | $196.35 | 4 | $785 | 0.9% |
| 5 | $197.72 | 92 | $18K | 19.9% |
| 6 | $199.22 | 23 |
| $5K |
| 5.0% |
| 7 | $200.02 | 30 | $6K | 6.6% |
| Total | $195.84 avg | 467 | $91K | 100% |
| Filing → |
| LGND | SELL | 2026-03-04 | $179K | — | Filing → |
| LGND | SELL | 2026-02-04 | $175K | — | Filing → |
| LGND | SELL | 2026-01-06 | $173K | — | Filing → |